We have now seen five undercover videos from the Center for Medical Progress. Each has taken us a little further down the rabbit hole to new depths of the depravity of the abortion culture in America. Planned Parenthood, the falsely-labeled “non-profit women's health organization” at the center of the depravity, has been caught numerous times negotiating the for-profit sale of aborted human fetuses, either in whole or in part.

The other company that has been implicated through the release of these videos is a California based firm called StemExpress. StemExpress, according to their website, provides certain biological specimens for use in research labs by essentially becoming the middle man. They stay within the letter of the law by “facilitating access” rather than selling specimens.

StemExpress was started in 2010 by Cate Dyer, who had formerly worked in a hospital as a procurement specialist. During the time she spent harvesting legal medical specimens for research, she became acutely aware that the research firms were always looking for more specimens, and for specimens of particular types. She began StemExpress in an effort to fill those needs.

In 2010, with an initial investment of just $9000, StemExpress turned a healthy profit by raking in over $150,000. But it was a few years later that things began to get, well, interesting.

Because StemExpress is a privately held company, financial statements are not public record – but in 2014, Dyer and StemExpress were recognized by Inc.com in the “Inc. 5000.” Citing growth of 1300%, they listed StemExpress's 2013 revenue at $2.2 million. Considering the fact that Dyer mostly advertised by word of mouth during her first few years in business, one has to wonder what accounts for such a drastic increase in revenue. Perhaps, for example, she landed a very large and lucrative account.

The financial specifics and StemExpress's client list (both providers and those they provide specimens to) are not public record, but this is the approximate timeline of events:

In 2012, StemExpress first began advertising the availability of fetal organs on their website.
Later same year, the company moved from its first brick-and-mortar location to a 17,000 square foot, state of the art facility.
Around that same time, Planned Parenthood provided a promotional statement for placement on the StemExpress website – a statement that lauded the partnership between StemExpress and Planned Parenthood.
StemExpress netted over $6 million in revenue in 2014.

So what happened between 2010 and 2013 to put StemExpress on the map? Does their partnership with Planned Parenthood have a connection to their rapid revenue growth? The timeline certainly lends itself to the suspicion, and I don't believe in coincidence.